NanoVibronix Extends Reach of UroShield and PainShield through MTSG`s International Network
NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has signed an International Marketing, Sales and Clinical Management Agreement with Medtech Solutions Group (“MTSG”), a leader in the commercialization of healthcare technologies.
The agreement allows MTSG to commercialize UroShield® and PainShield® throughout Europe, excluding the United Kingdom, Ireland, Malta and Turkey; Asia Pacific, Africa, Central and South America and certain parts of the Middle East. This agreement expands the Company’s addressable market by tens of millions of dollars and should enable availability of its products to new populations of patients.
“The agreement with MTSG represents an important milestone for our Company,” said Brian Murphy, CEO of NanoVibronix. “For the first time in company history, our products are now expected to be introduced around the world to millions of new patients through qualified distributors and dealers. MTSG team members have more than seven decades of global success in launching products and brand expansion for leading brands and healthcare products. We are pleased to add UroShield® and PainShield® to their portfolio and look forward to working closely with them to achieve mutual success. We are excited to introduce our products to their vast, existing distribution network through their sales professionals.”
Ron Dziedziula, Chief Operating Officer of MTSG, stated, “We are eager to work with NanoVibronix to accelerate the growth of UroShield® and PainShield® globally. Our team has a proven history of partnering with our clients and our expanding network of distributors to develop and implement marketing, sales and clinical strategies that increase product placements and drive international revenue growth for the clients we serve. We look forward to doing the same for NanoVibronix.”
About NanoVibronix, Inc.
NanoVibronix, Inc. (NASDAQ: NAOV) is a medical device company headquartered in Elmsford, New York, with research and development in Nesher, Israel, focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The proprietary technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company’s primary products include PainShield® and UroShield®, which are portable devices suitable for administration at home without assistance of medical professionals. Additional information about NanoVibronix is available at: www.nanovibronix.com .
About MedTech Solutions Group
MedTech Solutions Group (MTSG) is a private company headquartered in San Antonio, Texas with regional offices in London, England, Munich, Germany, Brisbane, Australia, and Mexico City, Mexico. MTSG was founded to provide medical device manufacturers with an option to contract with an experienced team already in place around the world to accelerate the international revenue of our clients’ brands. MTSG grows our clients brands at a country level through an expanding network of professional distributors who know their markets; led by the Regional MTSG Team Member who works with their distributor partners to grow MTSG managed brands; supported by HQ MTSG Team Members who manage the overall execution of the commercialization plan for each client.